Polygiene AB (DE:44P)
FRANKFURT:44P
44P Stock Chart & Stats
€0.82
>-€0.01(-0.42%)
At close: 4:00 PM EST
€0.82
>-€0.01(-0.42%)
Day’s Range― - ―
52-Week Range€0.44 - €1.24
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€18.90M
Enterprise Value€171.65M
Total Cash (Recent Filing)€43.50M
Total Debt (Recent Filing)€2.56M
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Jul 23, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding36,526,990
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)1.22
Price to Sales (P/S)2.30
P/FCF Ratio-30.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.07
Revenue Forecast (FY)€15.62M
Bulls Say, Bears Say
Bulls Say
Very Low Leverage / Strong Balance SheetA very low debt-to-equity ratio (~0.02) materially reduces solvency risk and provides financial flexibility. Over the next 2–6 months this balance-sheet strength gives the company runway to support commercialization, absorb short-term cash burn, and invest selectively in partnerships or R&D without refinancing pressure.
Solid Gross Margins On Treated ProductsA ~48% gross margin indicates the company captures meaningful value from its treatment technologies. Durable gross margins support future operating leverage if revenue stabilizes, enabling incremental profitability as scale rises and fixed costs are absorbed, assuming commercial adoption improves.
Asset-light Licensing + Treatment Business ModelAn asset-light model combining per-unit treatment sales and licensing/brand programs supports scalable revenue and recurring-like economics. Structural licensing upside can boost margins and cash flow over time without large capital expenditure, provided adoption across brands and mills grows.
Bears Say
Revenue Decline And Current LossesContracting revenue and a negative TTM net margin (~-14.7%) show earnings weakness and earnings volatility. Persistent operating losses undermine internal funding for growth, raise the bar for margin recovery, and mean management must improve commercial traction or restructure costs to restore sustainable profitability.
Negative Operating And Free Cash FlowRecent negative operating and free cash flow indicate the business is burning cash when measured over the trailing year. That reduces optionality for investments and requires either balance-sheet drawdown or external funding if losses persist, constraining strategic initiatives and dampening long-term execution flexibility.
Revenue Dependent On Partner Adoption And VolumesThe company’s growth depends on external brands, mills and manufacturers specifying and producing treated goods. That structural dependency exposes revenue to partner procurement cycles, customer concentration and apparel industry cyclicality, which can slow scaling and make revenue less predictable.
Polygiene AB News
44P FAQ
What was Polygiene AB’s price range in the past 12 months?
Polygiene AB lowest stock price was €0.44 and its highest was €1.24 in the past 12 months.
What is Polygiene AB’s market cap?
Polygiene AB’s market cap is €18.90M.
When is Polygiene AB’s upcoming earnings report date?
Polygiene AB’s upcoming earnings report date is Jul 23, 2026 which is in 43 days.
How were Polygiene AB’s earnings last quarter?
Polygiene AB released its earnings results on Apr 23, 2026. The company reported -€0.003 earnings per share for the quarter, missing the consensus estimate of €0.016 by -€0.019.
Is Polygiene AB overvalued?
According to Wall Street analysts Polygiene AB’s price is currently Overvalued.
Does Polygiene AB pay dividends?
Polygiene AB does not currently pay dividends.
What is Polygiene AB’s EPS estimate?
Polygiene AB’s EPS estimate is 0.02.
How many shares outstanding does Polygiene AB have?
Polygiene AB has 36,526,990 shares outstanding.
What happened to Polygiene AB’s price movement after its last earnings report?
Polygiene AB reported an EPS of -€0.003 in its last earnings report, missing expectations of €0.016. Following the earnings report the stock price went down -2.933%.
Which hedge fund is a major shareholder of Polygiene AB?
Currently, no hedge funds are holding shares in DE:44P
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Polygiene AB
Based in Malmö, Sweden, and founded in 2005, Polygiene Group AB develops, produces, and markets advanced solutions designed to control odors and maintain freshness across a wide range of materials. These applications extend to clothing, athletic equipment, various textiles, and other products. The company's operations span globally, serving markets throughout the Middle East, Africa, the Asia Pacific region, the Americas, and Europe. Polygiene caters to a diverse portfolio of partners across sectors including sports and outdoor activities, fashion and lifestyle, industrial uses, workwear, hospitality, household items, pet care, healthcare, water management, and paper and packaging. Its entire product line is offered under the Polygiene brand. The company officially changed its name to Polygiene Group AB in June 2022, having previously operated as Polygiene AB (publ.).
Technical Analysis
Nexam Chemical Holding AB
―
―
LifeClean International AB
―
aXichem AB Class A
―
OrganoClick AB
―